| European Case Law Identifier: | ECLI:EP:BA:1991:T056090.19910319 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Date of decision: | 19 March 1991 | ||||||||
| Case number: | T 0560/90 | ||||||||
| Application number: | 83303962.1 | ||||||||
| IPC class: | A61K 9/06 | ||||||||
| Language of proceedings: | EN | ||||||||
| Distribution: | |||||||||
| Download and more information: |
|
||||||||
| Title of application: | Topical anti-inflammatory compositions | ||||||||
| Applicant name: | Pfizer Corporation | ||||||||
| Opponent name: | Hexal-Pharma | ||||||||
| Board: | 3.3.02 | ||||||||
| Headnote: | - | ||||||||
| Relevant legal provisions: | |||||||||
| Keywords: | Appealable decisions - Time limit for appeal - Party status - Substantive procedural violation - Form of decision |
||||||||
| Catchwords: |
- |
||||||||
| Cited decisions: |
|
||||||||
| Citing decisions: |
|
||||||||
Source: http://www.epo.org/law-practice/case-law-appeals/recent/t900560eu1.html
Date retrieved: 17 May 2021
